Peramivir clinical trials
Also written Rapivab.
How each study uses peramivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the peramivir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Dec 2014 · RAPIVAB · NDA 206426 (FDA, Drugs@FDA)
- European Union
- 13 Apr 2018 · Alpivab · EMEA/H/C/004299 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 5
BioCryst Pharmaceuticals (10) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Johns Hopkins University (1) · Chinese University of Hong Kong (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
Oseltamivir (3) · Favipiravir (1) · Zanamivir (1) · Baloxavir (1) · Molnupiravir (1) · Laninamivir (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test peramivir.
- Jan 2027A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaPhase 2 · University of Oxford
Studies
Open first, then newest update. How each study uses peramivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as PeramivirHow we know
- A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.WithdrawnPhase 3BioCryst PharmaceuticalsNCT01224795Written as PeramivirHow we know
- Intramuscular Peramivir for the Treatment of Uncomplicated InfluenzaWithdrawnPhase 3BioCryst PharmaceuticalsNCT00486980Written as Peramivir 150mgHow we know
- Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT02635724Written as PeramivirHow we know
- Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT02369159Written as PeramivirHow we know
- Intramuscular Peramivir in Subjects With Uncomplicated Acute InfluenzaTerminatedPhase 3BioCryst PharmaceuticalsNCT00610935Written as PeramivirHow we know
- ED Influenza Therapeutic Pilot Study: Oseltamivir vs. PeramivirCompletedPhase 4Johns Hopkins UniversityNCT02609399Written as PeramivirHow we know
- Safety and Dose Study of Peramivir for Influenza TreatmentCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00297050Written as PeramivirHow we know
- Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract InfectionsCompletedPhase 2/3Chinese University of Hong KongNCT02665351Written as PeramivirHow we know
- A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute InfluenzaCompletedPhase 2BioCryst PharmaceuticalsNCT00705406Written as PeramivirHow we know
- Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.CompletedPhase 2BioCryst PharmaceuticalsNCT00419263Written as Peramivir 150 mgHow we know
- Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT00957996Written as PeramivirHow we know
- Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening InfluenzaCompletedPhase 2BioCryst PharmaceuticalsNCT00453999Written as Peramivir 200 mgHow we know
- A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to InfluenzaTerminatedPhase 3BioCryst PharmaceuticalsNCT00958776Written as Peramivir+SOCHow we know
- Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With InfluenzaWithdrawnPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT01063933Written as PeramivirHow we know
Codes
What other systems call peramivir · ClinicalTrials.gg INT004271
- MeSH (NLM) C414210peramivirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) QW7Y7ZR15UPERAMIVIRConfirmed FDA, NLM, Wikidata
- RxNorm 619693Confirmed FDA, Wikidata
- Wikidata Q47495829peramivir trihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81611PeramivirConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C414210 | peramivir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | QW7Y7ZR15U | PERAMIVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 619693 | — | Confirmed FDA, Wikidata |
| Wikidata | Q47495829 | peramivir trihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81611 | Peramivir | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.